Net Asset Value of Global Healthcare & Bio Fund Rises
Published
In the investment trust market, the net asset value (NAV) of the attention-grabbing "Global Healthcare & Bio Fund" has increased. According to the latest data, the NAV rose by 210 yen from the previous day to 9,552 yen, marking an increase of 2.25%.
This fund invests in healthcare and biotechnology-related companies around the world. Currently, its net assets exceed 211.3 billion yen, indicating that it is attracting interest from many investors. Furthermore, approximately 5.7 billion yen in capital has flowed into the fund over the past month, reflecting high expectations from investors.
On the other hand, it is important to be mindful of costs when choosing an investment trust. The trust fee for this fund is set at 2.42%. Trust fees are commissions paid by investors to management companies and other entities, and they are an important factor that affects long-term investment performance.
Investment trust prices fluctuate daily depending on market conditions. While this rise in NAV reflects current market trends, when considering an investment, it is important to thoroughly understand the fund's structure and fees, and to make careful decisions based on your own financial situation.
Sources: Yahoo!ファイナンス
More Japan news
- Toyota, Nissan and Honda to Hold Engineer Event in Fiscal 2026 Under the Theme of “AI”
- HTC NIPPON Promotes Business Use of the Smart Glasses "VIVE Eagle" as Sponsor of Remote Guidance App Exhibition
- Defense-Related ETF "GX Defense Tech" Publishes Stock Price Information; Detailed News Not Available
- U.S. Ambassador to South Korea Marks 100 Days in Office, Stresses the Importance of Protecting Trust Between South Korea and the United States
- South Korean National Assembly Passes Special Counsel Act to Investigate "Fabricated Indictments"
- Former Professor Embroiled in Stem Cell Paper Fabrication Scandal Acquires UAE Citizenship, Loses South Korean Nationality
- Foreign Minister Motegi Holds Talks with Foreign Ministers of France, Italy and the UK, Calls for Appropriate Response on EU Exclusion of Japanese-Made EVs from Preferential Treatment
- Health Drink Market in Japan Set to Grow, Driven by Aging Population and Health Consciousness